心外管道Fontan患者的远期结局:32年随访
本研究回顾性分析了1988年11月至2015年11月在本机构接受心外管道Fontan手术的406例患者,随访至2020年9月。中位随访14.6年,32年生存概率为84%,54%患者长期结局良好,但34%需介入或外科再手术,12%发生晚期Fontan失败。术前诊断为左心发育不良综合征是需要心脏移植的独立危险因素。
要点
- 心外管道Fontan术后32年生存概率为84%,54%患者无事件长期生存。
- 34%患者发生需介入或外科再手术的晚期不良事件,12%发生晚期Fontan失败。
- 术前左心发育不良综合征是需要心脏移植的独立危险因素。
核心结论
- 心外管道Fontan显示出令人满意的长期生存和较低的不良事件及晚期失败发生率。
- 管道置换罕见,其耐久性可能不是这些患者的主要问题。
- 然而,与其他技术变体一样,长期随访期间需要再手术是一个重大挑战。
研究设计与样本
- 收集并分析本机构1988年11月至2015年11月接受心外管道Fontan手术的所有患者的随访数据,截至2020年9月。
- 共406例患者接受心外管道Fontan,平均年龄5.4 ± 4.5岁。
主要发现
- 406例患者中372例(91.6%)出院回家,15%失访。
- 中位随访14.6年(四分位距8.7-20.3)。
- 200例患者(54%)长期结局良好,无事件长期生存。
- 128例患者(34%)报告了需要介入或外科再手术的晚期不良事件。
- 44例患者(12%)发生晚期Fontan失败。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We sought to evaluate the long-term survival and risk factors for morbidity and mortality in our cohort of patients after extracardiac (EC) Fontan. METHODS: We collected and analysed follow-up data until September 2020 for all patients who underwent EC Fontan operation at our institution from November 1988 to November 2015. RESULTS: Out of 406 patients treated with EC Fontan at a mean age of 5.4 ± 4.5 years, 372 (91.6%) were discharged home; 15% were lost to follow-up. The median follow-up was 14.6 years (interquartile range 8.7-20.3). Two hundred patients (54%) had a good long-term outcome, with an event-free long-term survival, but late adverse events of any kind needing interventional or surgical reoperations were reported in 128 patients (34%). Forty-four patients (12%) developed late Fontan failure. Thirty-seven survivors (10%) had late arrhythmias, with the need for pacemaker implantation. Obstruction of the cavopulmonary pathway occurred in 49 patients (13%), but just 8 patients needed conduit surgical replacement. At 32 years, the survival probability was 84%. The risk of orthotopic heart transplant, considering death as a competing event (showed as cumulative incidence), was 12.5%. A preoperative diagnosis of hypoplastic left heart syndrome was an independent risk factor for the need for heart transplant. CONCLUSIONS: The EC Fontan shows satisfactory long-term survival and low incidence of adverse events and late failure. Conduit replacement is rare, and its longevity may not represent a substantial issue in these patients. However, as with other technical variants, the need for reoperations during long-term follow-up is a significant challenge.
引用
- Giannico S, Trezzi M, Cantarutti N, et al. Late outcome of extracardiac Fontan patients: 32 years of follow-up. Eur J Cardiothorac Surg. 2022. PMID: 35543463. doi:10.1093/ejcts/ezac301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。